Register for course

Speaker: Dr. Arthur H. Jeske

Abstract: The ever-increasing death rate associated with the opioid epidemic has brought emergency opioid overdose reversal into the spotlight. With the increased potency and duration of new illicitly-manufactured fentanyl analogs, new strategies for effective opioid reversal are emerging, including the introduction of new opioid antagonists. Additionally, there are parallel concerns for adverse reactions to opioid overdose reversal, including the opioid withdrawal syndrome. This course summarizes current scientific evidence and opinion on the issues surrounding emergency opioid reversal.

Learning Objectives:

At the conclusion of this course, participants will be able to:

1. Review the pharmacologic characteristics of opioid antagonists
2. Describe the signs and symptoms of opioid antagonists
3. Review the currently recommended methods of administration and dosages of antagonists used to reverse opioid overdose
4. Describe the potential adverse effects of opioid reversal and their management

Tuition: $59/1.5 ADA CERP credit hours
Course Prerequisites: None required 
Course Format: Virtual Lecture
Conflict of Interest: None reported by speaker
Contact: Caitlin Laughlin at caitlin_laughlin@hsdm.harvard.edu
Cancellation Policy: Cancellation 7 days before the course will be eligible for full refund. No refund will be made within 7 days of the course initiation date. 

Harvard School of Dental Medicine is an ADA CERP Recognized Provider
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. The Harvard School of Dental Medicine designated this activity for 1 continuing education credit.